Vimarsana
Biggest News Aggregation in the World

Page 31 - Ace2 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ace2. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ace2 Today - Breaking & Trending Today

Study shows asthma mediator IL-13 prevents SARS-CoV-2 infection - Vimarsana News

Study shows asthma mediator IL-13 prevents SARS-CoV-2 infection

In a paper published on the bioRxiv preprint server, researchers reported the results on whether IL-13 expression in asthma patients reduces their susceptibility to SARS-CoV-2 infection.

SARS-CoV-2 UK variant shows low virulence and high shedding in hamster model - Vimarsana News

SARS-CoV-2 UK variant shows low virulence and high shedding in hamster model

A new study compares the pathogenicity and infectiousness of one such variant, the VOC 202012/01 (B.1.1.7 lineage) from the United Kingdom, with the globally dominant D614G mutation-carrying strains.

Evonik partners with BioNTech to manufacture lipids for COVID-19 vaccine - Vimarsana News

Evonik partners with BioNTech to manufacture lipids for COVID-19 vaccine

Evonik partners with BioNTech to manufacture lipids for COVID-19 vaccine Caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus disease 2019 (COVID-19) pandemic continues to spread across the globe. The rise to dominance of several new variants of concern, some with observed heightened transmissibility, has contributed to a resurgence in cases in many parts of the world – particularly in the U.S., the U.K., Brazil, and South Africa. To date, over 107 million cases of COVID-19 have been confirmed worldwide, with over 2.35 million deaths. Since the v...

Comparative analysis of SARS-CoV-2 antivirals leads to new potential treatment for COVID-19 - Vimarsana News

Comparative analysis of SARS-CoV-2 antivirals leads to new potential treatment for COVID-19

Comparative analysis of SARS-CoV-2 antivirals leads to new potential treatment for COVID-19 A rapid spread of the virus that caused symptoms similar to severe pneumonia was first reported in Wuhan, China, in December 2019. Scientists found that this novel virus belonged to the family Coronaviridae and was later named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Worldwide, researchers are developing various vaccines, medicines, facemasks, and many other means to contain the SARS-CoV-2 infection. Among various antiviral drugs, remdesivir has been approved for the treatment of c...

New paper discusses how smoking may affect risk for COVID-19 - Vimarsana News

New paper discusses how smoking may affect risk for COVID-19

New paper discusses how smoking may affect risk for COVID-19 A new paper published online in the Annals of the American Thoracic Society discusses how smoking may affect risk for COVID-19 and the types of research that are needed to better understand the link between smoking and COVID-19 risk. In "Smoking and COVID-19: The Real Deal," Enid Neptune, MD, and Michelle N. Eakin, PhD, of the Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, discuss research to date on this topic and propose areas of research that can help clarify this relationship. Studies have shown that...